InvestorsHub Logo
Followers 249
Posts 28299
Boards Moderated 2
Alias Born 08/21/2003

Re: Billybob_TX post# 315693

Friday, 11/17/2017 11:30:37 AM

Friday, November 17, 2017 11:30:37 AM

Post# of 380443
My thought too...sometimes it's better action too...I just add dips heavier:

In addition, a phase 3 trial evaluating the safety and efficacy of Egalet-002 in patients with moderate-to-severe chronic pain is expected to be completed by year end.

that's next month...

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.